150 participants
A Study to Assess the Efficacy, Safety and Tolerability of AT673 Co-administered With Semaglutide in Adult Participants With Type 2 Diabetes (T2D) and Overweight or Obesity
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-09-01
- Start Date:
- 2026-06-19
- Completion:
- 2027-02-28
Conditions
- Adults With Overweight/Obesity and Type 2 Diabetes
Interventions
- DRUG
No Results Yet